In addition, CMTM3 overexpression significantly downregulates the phosphorylation levels of JAK2 and STAT3 in HepG2 cells, which suggests that CMTM3 suppresses HCC cell proliferation and tumorigenesis by inhibiting the JAK2/STAT3 signaling pathway. Here, STAT3 is linked to hepatocellular carcinoma.